Cargando…
MyD88 Deficiency, but Not Gut Microbiota Depletion, Is Sufficient to Modulate the Blood–Brain Barrier Function in the Mediobasal Hypothalamus
Circumventricular organs (CVOs), including the mediobasal hypothalamus (MBH), have an incomplete blood–brain barrier (BBB). In this study, we determined if the BBB function in the MBH is modulated by the gut microbiota or by the Toll-like receptor (TLR) adapter proteins TRIF or MyD88 signaling. By i...
Autores principales: | Heiss, Christina N., Gravert, Ellinor, Hultén, Matilda, Olofsson, Louise E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148286/ https://www.ncbi.nlm.nih.gov/pubmed/35381888 http://dx.doi.org/10.1007/s12035-022-02802-w |
Ejemplares similares
-
A riot of rhythms: neuronal and glial circadian oscillators in the mediobasal hypothalamus
por: Guilding, Clare, et al.
Publicado: (2009) -
MyD88 and beyond: a perspective on MyD88-targeted therapeutic approach for modulation of host immunity
por: Saikh, Kamal U.
Publicado: (2021) -
Schisandrin B Attenuates Diabetic Cardiomyopathy by Targeting MyD88 and Inhibiting MyD88‐Dependent Inflammation
por: Luo, Wu, et al.
Publicado: (2022) -
Metabolic Consequences of Neuronal HIF1α-Deficiency in Mediobasal Hypothalamus in Mice
por: Rozjan, Azmat, et al.
Publicado: (2021) -
A MyD88 meddles with survival
por: Bashyam, Hema
Publicado: (2007)